The potential targets in immunotherapy of atherosclerosis

Area of Science:

• Cardiovascular immunology
• Inflammatory diseases
• Atherosclerosis pathophysiology

Background:

• Cardiovascular disease is the leading global cause of mortality.
• Atherosclerosis, a chronic autoinflammatory vascular disease, underlies heart failure and stroke.
• Current treatments lack specific immunotherapies for atherosclerosis prevention and management.

Approach:

• Review of current literature on atherosclerosis pathophysiology.
• Exploration of immunological mechanisms in lipid plaque formation and vascular remodeling.
• Identification of novel immunomodulatory therapies and preventive strategies.

Key Points:

• Immune mediators play a critical role in atherosclerosis development.
• Understanding the autoinflammatory nature of atherosclerosis is key to new treatments.
• Immunotherapy offers a promising avenue for preventing and treating atherosclerosis.

Conclusions:

• Targeted immunotherapies and novel preventive approaches show significant potential for atherosclerosis.
• Further research into immunological pathways can lead to advanced biological therapies.
• Developing effective immunotherapies is crucial for reducing cardiovascular mortality.